Definitive Contract 75F40118C10136
Award Date
9/17/18
Potential Completion Date
3/16/20
Potential Value
$120K
Federal Agency
Food and Drug Administration
Awardee
Brigham & Womens Hospital Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
B599 - Special Studies/Analysis- Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02115, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, MA, to conduct a study titled "Risk Evaluation and Mitigation Strategy (REMS) Programs to Promote Appropriate Medication Use and Knowledge". The contract does not have a set-aside designation and has a potential value of $4,419,354.00. The completion date for this...
The Department of Health and Human Services Food and Drug Administration awarded a $2,963,836.42 firm fixed price delivery order contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract supports developing capability to use Medicaid data for FDA post-market drug safety surveillance during pregnancy. This contract is a task order under the FDA's Scientific Pharmacoepidemiologic Research Program, a larger...
The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation. Under the contract, Brigham & Women's Hospital is working closely with the FDA's...
This federal contract award, valued at $13,290.62, was issued by the U.S. Food and Drug Administration (FDA) to Brigham & Women's Hospital Inc., a prominent academic medical center and research institution affiliated with Harvard Medical School. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. The contract provides for research and development services at FDA facilities. Brigham & Women's Hospital Inc. is a subsidiary of the larger Partners Healthcare...
This is a $2,708,850.00 definitive contract awarded by the Food and Drug Administration (FDA) to Brigham & Women's Hospital Inc., a nonprofit academic medical center and research institution. The contract is for a two-stage process to use real-world evidence (RWE) to support labeling expansions for effectiveness claims, aligned with regulatory requirements. The contractor will demonstrate and empirically test this process using historical and ongoing randomized controlled trials (RCTs) for...
This is a task order awarded to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, by the Food and Drug Administration. The $91,189.41 firm-fixed-price task order is for support in providing communications expertise and planning annual meetings related to the agency's epidemiology initiatives. The award is not set aside for small businesses. Brigham & Women's Hospital Inc. has extensive experience providing specialized medical research and...
This federal contract award was made by the Food and Drug Administration (FDA) to Brigham & Women's Hospital Inc., a leading academic medical center and research institution affiliated with Harvard Medical School. The $1,455,759.50 Firm Fixed Price delivery order contract is for a Computerized Physician Order Entry (CPOE) system, which is closely associated with the FDA's medical research and healthcare technology initiatives. The contract does not have a small business set-aside...
This is a $5,654,163.32 firm fixed price delivery order contract awarded by the Franchise Acquisition Services agency to Brigham & Women's Hospital Inc., a major academic medical center and research institution in Boston, Massachusetts. The contract is for research subjects and has an ultimate completion date of December 31, 2024. Brigham & Women's Hospital is a subsidiary of the larger Partners Healthcare System Incorporated, which has a history of federal contract and grant awards,...
This firm fixed price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Brigham & Women's Hospital Inc., a non-profit organization, to develop clinical reporting forms, an associated backend database, and a modified front-end interface to support a study. The $153,820 contract has a completion date of December 29, 2020. Brigham & Women's is a subsidiary of the larger Partners Healthcare System Incorporated, which has a history of receiving...
This is a $2,000,000.00 federal contract award to Brigham & Women's Hospital Inc., a nonprofit academic medical center in Boston, Massachusetts. The contract was awarded by the National Institutes of Health (NIH) to support the hospital's work on the ADAPT program, focused on developing early multimodal data fusion methods for integrating radiology, histopathology, and genomics. This is an Other Transaction Agreement (OTA) with a period of performance through May 19, 2028. Brigham &...